CJC-1295 (no DAC) + Ipamorelin

The listing names CJC-1295 without DAC and Ipamorelin in a single powder vial. It is distinct from standalone CJC-1295, standalone Ipamorelin and the with-DAC CJC form.

10 mg describes the nominal total mixture. It does not establish 10 mg per component or a measured 5 mg/5 mg split. Component quantities require the blend specification and its applicable quantitative report.

CJC Ipa is informal shorthand for a CJC/Ipamorelin mixture. CJC1295 is a writing variant of CJC-1295. Mod GRF 1-29 is associated with no-DAC terminology. None of these abbreviations confirms DAC status, proportions or a batch identity.

Standalone Ipamorelin has a different ingredient list. Dividing a blend price by its total labelled mg cannot reveal the cost per mg of Ipamorelin alone.

The exact two-component no-DAC material needs its own evidence. A different molecular form or single-ingredient report cannot verify the complete mixture. Read the CJC forms and evidence guide.

10 mg identifies the nominal mass of the complete blend per vial. It does not specify a dose, a concentration in mg/mL or a measured-content result. Ingredient quantities must be assessed separately.

This page links Janoshik report #230353, an original source report naming Peptide Central UK as its client. The reported batch is 100245. This documents the submitted sample, not a verified connection to current EPS inventory. The COA library retains the original document and verification details.

Compare the compound, chemical form, vial amount, sample description and batch or lot number. Verify the report through the issuing laboratory using its identifier and key. Use the COA verification checklist.

Check which results the original report actually provides. Individual component quantities and any purity results need separate assessment. A purity percentage does not quantify milligrams per vial or establish sterility and endotoxin results. Those require their own stated tests. The label's ordering specification is not a measured batch result.

Use the purchase section on this page for the current EPS listing status. A displayed sample price or preview basket does not establish live inventory or a confirmed order. Where the page says Price at launch, no selling price has been confirmed. Contact EPS for product enquiries.

Divide the current single-vial price by 10 for cost per labelled mg. This uses total blend mass and does not give the cost per mg of any one ingredient. Include shipping and compare the same chemical form and documentation. An unpriced size cannot establish a lowest-cost option.

Follow verified storage instructions for the exact supplied material and batch. Storage of dry powder and a prepared solution are separate questions. A general temperature range or preservative does not establish stability or an expiry. Read the storage and stability record guide.

Use a procedure validated for the exact chemical form and intended assay. Confirm solvent compatibility, concentration, container capacity and stability evidence; no universal diluent or shelf life is established here. Read the laboratory preparation guide. EPS does not provide administration or dosing instructions.

EPS delivery destinations, dispatch origin, rates and times must be confirmed in the shipping information before orders open. A country page or catalogue listing is not a delivery guarantee. Dispatch promises from another retailer do not apply to EPS.

Keep the packaging and label, photograph the damage and contact EPS with the order and batch details. Read the EPS returns and withdrawal information for the applicable process and rights. Another retailer's return deadlines do not define EPS terms.

CJC-1295 (no DAC) + Ipamorelin 10 mg is listed for lawful in-vitro laboratory research as research material. It is not supplied for use in or on humans or animals. EPS does not provide dosing or self-administration guidance. Read the research use statement and assess the requirements that apply to the intended laboratory work.